Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lensar (LNSR) Other Non-Current Assets (2019 - 2025)

Lensar (LNSR) has disclosed Other Non-Current Assets for 7 consecutive years, with $2.9 million as the latest value for Q3 2025.

  • On a quarterly basis, Other Non-Current Assets rose 58.58% to $2.9 million in Q3 2025 year-over-year; TTM through Sep 2025 was $2.9 million, a 58.58% increase, with the full-year FY2024 number at $2.6 million, up 18.49% from a year prior.
  • Other Non-Current Assets was $2.9 million for Q3 2025 at Lensar, up from $2.3 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $3.6 million in Q1 2021 to a low of $1.8 million in Q3 2024.
  • A 5-year average of $2.7 million and a median of $2.6 million in 2024 define the central range for Other Non-Current Assets.
  • Peak YoY movement for Other Non-Current Assets: fell 21.1% in 2024, then skyrocketed 58.58% in 2025.
  • Lensar's Other Non-Current Assets stood at $3.2 million in 2021, then fell by 16.49% to $2.7 million in 2022, then fell by 17.8% to $2.2 million in 2023, then increased by 18.49% to $2.6 million in 2024, then increased by 12.01% to $2.9 million in 2025.
  • Per Business Quant, the three most recent readings for LNSR's Other Non-Current Assets are $2.9 million (Q3 2025), $2.3 million (Q2 2025), and $2.5 million (Q1 2025).